Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease

被引:50
|
作者
McNeal-Davidson, Ariane [1 ]
Fournier, Anne [1 ]
Spigelblatt, Linda [4 ]
Saint-Cyr, Claire [2 ]
Mir, Thomas S. [7 ]
Nir, Amiram [8 ]
Dallaire, Frederic [5 ,6 ]
Cousineau, Jocelyne [3 ]
Delvin, Edgard [3 ]
Dahdah, Nagib [1 ]
机构
[1] Univ Montreal, Dept Pediat, Div Pediat Cardiol, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Dept Pediat, Div Pediat Rhumatol & Immunol, Montreal, PQ H3C 3J7, Canada
[3] Univ Montreal, St Justine Univ Hosp Ctr, Dept Clin Biochem, Montreal, PQ H3C 3J7, Canada
[4] Maisonneuve Rosemont Hosp, Dept Pediat, Montreal, PQ, Canada
[5] Laval Univ Hosp Ctr, Dept Pediat, Div Pediat Cardiol, Quebec City, PQ, Canada
[6] Univ Laval, Quebec City, PQ, Canada
[7] Hamburg Eppendorf Univ Hosp, Clin & Polyclin Pediat Cardiol, Hamburg, Germany
[8] Hadassah Hebrew Univ Med Ctr, Jerusalem, Israel
关键词
echocardiography; incomplete criteria; incomplete Kawasaki disease; mucocutaneous lymph node syndrome; NT-proBNP; AMERICAN-HEART-ASSOCIATION; GAMMA-GLOBULIN; CARDIOVASCULAR-DISEASE; PEDIATRIC POPULATION; DIASTOLIC FUNCTION; ACUTE-PHASE; CHILDREN; BRAIN; STATEMENT; YOUNG;
D O I
10.1111/j.1442-200X.2012.03609.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The aim of the present study was to investigate the diagnostic value of the N-terminal B-type natriuretic peptide (NT-proBNP) in acute Kawasaki disease (KD) given that the clinical criteria and the current basic laboratory tests lack the necessary specificity for accurate diagnosis. Methods: Basic biological tests and serum NT-proBNP levels obtained from acute KD patients were compared to that of febrile controls. NT-proBNP was considered abnormal based on the following definitions: above a cut-off determined on receiver operator characteristic (ROC) analysis, above the upper limit for age, or above 2 SD calculated from healthy children. Analyses were also performed for KD cases with complete or incomplete criteria combined and separately. Results: There were 81 patients and 49 controls aged 3.60 +/- 2.77 versus 4.25 +/- 3.88 years (P= 0.69). ROC analysis yielded significant area under the curve for NT-proBNP. The sensitivity, specificity, positive and negative predictive values were 70.488.9%, 69.491.8%, 82.893.4%, and 65.279.1%. The odds ratios based on NT-proBNP definitions varied between 18.13 (95% confidence interval [CI]: 7.2145.57), 20.82 (95%CI: 8.1853.0), and 26.71 (95%CI: 8.6482.57; P < 0.001). Results were reproducible for cases with complete or incomplete criteria separately. Conclusion: NT-proBNP is a reliable marker for the diagnosis of KD. Prospective clinical studies with emphasis on NT-proBNP in a diagnostic algorithm are needed.
引用
收藏
页码:627 / 633
页数:7
相关论文
共 50 条
  • [1] Amino-Terminal Pro-B-Type Natriuretic Peptide in Refractory Kawasaki Disease
    de Benedictis, Fernando Maria
    Colaneri, Massimo
    Osimani, Patrizia
    Bettuzzi, Maria Grazia
    PEDIATRIC CARDIOLOGY, 2009, 30 (06) : 837 - 839
  • [2] Alterations of natriuretic peptides amino-terminal pro B-type natriuretic peptide and amino-terminal pro C-type natriuretic peptide during the pregnancy
    Tekin, Yesim Bayoglu
    Guven, Emine Seda Guvendag
    Kirbas, Aynur
    Cobanoglu, Ugur
    Colak, Sabri
    Dogan, Osman Deniz
    Sahin, Figen Kir
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (11) : 1103 - 1107
  • [3] Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation
    Giannopoulos, Georgios
    Kossyvakis, Charalampos
    Angelidis, Christos
    Efremidis, Michael
    Panagopoulou, Vasiliki
    Letsas, Konstantinos
    Bouras, Georgios
    Vassilikos, Vassilios P.
    Goudevenos, John
    Tousoulis, Dimitrios
    Lekakis, John
    Deftereos, Spyridon
    HEART RHYTHM, 2015, 12 (07) : 1470 - 1475
  • [4] N-terminal pro-brain natriuretic peptide in acute Kawasaki disease correlates with coronary artery involvement
    Adjagba, Philippe M.
    Desjardins, Laurent
    Fournier, Anne
    Spigelblatt, Linda
    Montigny, Martine
    Dahdah, Nagib
    CARDIOLOGY IN THE YOUNG, 2015, 25 (07) : 1311 - 1318
  • [5] EVOLUTION OF AMINO-TERMINAL PRO-B TYPE NATRIURETIC PEPTIDE TESTING IN HEART FAILURE
    Januzzi, James L.
    Bayes-Genis, Antoni
    DRUG NEWS & PERSPECTIVES, 2009, 22 (05) : 267 - 273
  • [6] Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
    Zachariah, Justin P.
    Aliku, Twalib
    Scheel, Amy
    Hasan, Babar S.
    Lwabi, Peter
    Sable, Craig
    Beaton, Andrea Z.
    ANNALS OF PEDIATRIC CARDIOLOGY, 2016, 9 (02) : 120 - 125
  • [7] B-type Natriuretic Peptide and Amino-terminal Pro-B-type Natriuretic Peptide in Pediatric Patients with Pulmonary Arterial Hypertension
    Takatsuki, Shinichi
    Wagner, Brandie D.
    Ivy, David Dunbar
    CONGENITAL HEART DISEASE, 2012, 7 (03) : 259 - 267
  • [8] Association of Amino-terminal Pro-brain Natriuretic Peptide with Metabolic Syndrome
    Li, Wen-Yi
    Chiu, Fu-Chun
    Chien, Yu-Fen
    Lin, Jou-Wei
    Hwang, Juey-Jen
    INTERNAL MEDICINE, 2011, 50 (11) : 1143 - 1147
  • [9] Amino-terminal pro-C-type natriuretic peptide in heart failure
    Wright, SP
    Prickett, TCR
    Doughty, RN
    Frampton, C
    Gamble, GD
    Yandle, TG
    Sharpe, N
    Richards, M
    HYPERTENSION, 2004, 43 (01) : 94 - 100
  • [10] N-terminal probrain natriuretic peptide as biomarker for diagnosis of Kawasaki disease
    Rodriguez-Gonzalez, Moises
    Perez-Reviriego, Alvaro A.
    Castellano-Martinez, Ana
    Cascales-Poyatos, Helena M.
    BIOMARKERS IN MEDICINE, 2019, 13 (04) : 307 - 323